Healthcare -
Biotechnology - NASDAQ - US
$ 24.06
-12.2 %
$ 9.28 B
Market Cap
-2.8
P/E
MRNA - REVENUE
Revenue MRNA - Moderna, Inc.
3.24 B
LAST VALUE
-59.01%
2 YEAR CAGR
132.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR